The Panelists:
Linda Costa
Johns Hopkins Hospital
"Nursing-Pharmacy Collaboration on Medication Reconciliation: A Novel Approach to Information Management"
Deficits in communication across the continuum of care in regards to medication use can place patients at serious risk for harm. This interdisciplinary team is examining how to economically support direct care providers in medication reconciliation in order to facilitate safe transition to and from hospital and community. The team is evaluating the effectiveness of a nurse-pharmacist clinical information coordination team in improving drug information management on admission and discharge, quantify potential harm due to reconciliation failures, and determine cost-benefit related to averted harm.
Jill Marsteller
Johns Hopkins University
"Linking Blood Stream Infection Rates to Intensive Care"
The goal of this study was to implement a comprehensive safety program including an evidence based intervention to reduce central line-associated blood stream infections while examining the context of nursing care delivery on patient outcomes. This interdisciplinary research team used the expertise of nurses to develop and deliver a quality improvement initiative that reflects the positive clinical contributions of nurses in the critical care setting. This study should inform other nurse-led medical error reduction interventions, contribute to the quality improvement literature and to the science of rigorously evaluated evidence based interdisciplinary nursing practice.
Linda Flynn
University of Maryland
"Examining the Impact of Nursing Structures and Processes on Medication Errors"
The Institute of Medicine noted that a hospital patient on average is subject to at least one medication error per day, making medication errors the most common cause of preventable adverse events. This interdisciplinary study has been designed to disentangle the effects of nursing structures and care processes on non-intercepted medication errors in acute care hospitals. The economic impact of non-intercepted medication errors will be determined to explore the business case for evidence-based recommendations.